Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia.

Jin Q, Martinez CA, Arcipowski KM, Zhu Y, Gutierrez-Diaz BT, Wang KK, Johnson MR, Volk AG, Wang F, Wu J, Grove C, Wang H, Sokirniy I, Thomas PM, Goo YA, Abshiru NA, Hijiya N, Peirs S, Vandamme N, Berx G, Goosens S, Marshall SA, Rendleman EJ, Takahashi YH, Wang L, Rawat R, Bartom ET, Collings CK, Van Vlierberghe P, Strikoudis A, Kelly S, Ueberheide B, Mantis C, Kandela I, Bourquin JP, Bornhauser B, Serafin V, Bresolin S, Paganin M, Accordi B, Basso G, Kelleher NL, Weinstock J, Kumar S, Crispino JD, Shilatifard A, Ntziachristos P.

Clin Cancer Res. 2018 Sep 17. doi: 10.1158/1078-0432.CCR-18-1740. [Epub ahead of print]

PMID:
30224337
2.

Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging.

Melgar-Asensio I, Kandela I, Aird F, Darjatmoko SR, de Los Rios C, Sorenson CM, Albert DM, Sheibani N, Henkin J.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4071-4081. doi: 10.1167/iovs.18-24087.

3.

Flexible Transient Optical Waveguides and Surface-Wave Biosensors Constructed from Monocrystalline Silicon.

Bai W, Yang H, Ma Y, Chen H, Shin J, Liu Y, Yang Q, Kandela I, Liu Z, Kang SK, Wei C, Haney CR, Brikha A, Ge X, Feng X, Braun PV, Huang Y, Zhou W, Rogers JA.

Adv Mater. 2018 Aug;30(32):e1801584. doi: 10.1002/adma.201801584. Epub 2018 Jun 26.

PMID:
29944186
4.

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.

Frankowski KJ, Wang C, Patnaik S, Schoenen FJ, Southall N, Li D, Teper Y, Sun W, Kandela I, Hu D, Dextras C, Knotts Z, Bian Y, Norton J, Titus S, Lewandowska MA, Wen Y, Farley KI, Griner LM, Sultan J, Meng Z, Zhou M, Vilimas T, Powers AS, Kozlov S, Nagashima K, Quadri HS, Fang M, Long C, Khanolkar O, Chen W, Kang J, Huang H, Chow E, Goldberg E, Feldman C, Xi R, Kim HR, Sahagian G, Baserga SJ, Mazar A, Ferrer M, Zheng W, Shilatifard A, Aubé J, Rudloff U, Marugan JJ, Huang S.

Sci Transl Med. 2018 May 16;10(441). pii: eaap8307. doi: 10.1126/scitranslmed.aap8307.

5.

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer.

Shan X, Danet-Desnoyers G, Aird F, Kandela I, Tsui R, Perfito N, Iorns E.

PeerJ. 2018 Apr 16;6:e4661. doi: 10.7717/peerj.4661. eCollection 2018.

6.

Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Aird F, Kandela I, Mantis C; Reproducibility Project: Cancer Biology.

Elife. 2018 Jan 8;7. pii: e34572. doi: 10.7554/eLife.34572. No abstract available.

7.

6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.

Liu Y, Lou G, Norton JT, Wang C, Kandela I, Tang S, Shank NI, Gupta P, Huang M, Avram MJ, Green R, Mazar A, Appella D, Chen Z, Huang S.

FASEB J. 2017 Dec;31(12):5453-5465. doi: 10.1096/fj.201700306RR. Epub 2017 Aug 17.

PMID:
28821631
8.

Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice.

Kandela IK, McAuliffe KJ, Cochran LE, Barrett AGM, Hoffman BM, Mazar AP, Trivedi ER.

ACS Med Chem Lett. 2017 Jun 29;8(7):705-709. doi: 10.1021/acsmedchemlett.7b00063. eCollection 2017 Jul 13.

9.

Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies.

Hartlieb KJ, Ferris DP, Holcroft JM, Kandela I, Stern CL, Nassar MS, Botros YY, Stoddart JF.

Mol Pharm. 2017 May 1;14(5):1831-1839. doi: 10.1021/acs.molpharmaceut.7b00168. Epub 2017 Apr 12.

PMID:
28355489
10.

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Aird F, Kandela I, Mantis C; Reproducibility Project: Cancer Biology.

Elife. 2017 Jan 19;6. pii: e21253. doi: 10.7554/eLife.21253. Erratum in: Elife. 2018 Jan 08;7:.

11.

Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Kandela I, Aird F; Reproducibility Project: Cancer Biology.

Elife. 2017 Jan 19;6. pii: e17044. doi: 10.7554/eLife.17044.

12.

Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Mantis C, Kandela I, Aird F; Reproducibility Project: Cancer Biology.

Elife. 2017 Jan 19;6. pii: e17584. doi: 10.7554/eLife.17584.

13.

Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.

Hendrix MJ, Kandela I, Mazar AP, Seftor EA, Seftor RE, Margaryan NV, Strizzi L, Murphy GF, Long GV, Scolyer RA.

Lab Invest. 2017 Feb;97(2):176-186. doi: 10.1038/labinvest.2016.107. Epub 2016 Oct 24.

14.

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Ravi D, Beheshti A, Abermil N, Passero F, Sharma J, Coyle M, Kritharis A, Kandela I, Hlatky L, Sitkovsky MV, Mazar A, Gartenhaus RB, Evens AM.

Cancer Res. 2016 Jun 1;76(11):3319-31. doi: 10.1158/0008-5472.CAN-15-2477. Epub 2016 Mar 17.

15.

Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Kandela I, Jin HY, Owen K; Reproducibility Project: Cancer Biology.

Elife. 2015 Jun 25;4:e07072. doi: 10.7554/eLife.07072.

16.

Correction: Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Kandela I, Chou J, Chow K; Reproducibility Project: Cancer Biology.

Elife. 2015 Jun 8;4. doi: 10.7554/eLife.09169. No abstract available.

17.

Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Kandela I, Chou J, Chow K; Reproducibility Project: Cancer Biology; Reproducibility Project Cancer Biology.

Elife. 2015 May 22;4. doi: 10.7554/eLife.06959. Erratum in: Elife. 2015;4. doi: 10.7554/eLife.09169.

18.

Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Kandela I, Chou J, Chow K; Reproducibility Project: Cancer Biology.

Elife. 2015 May 22;4. pii: e06959. doi: 10.7554/eLife.06959.

19.

Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data.

Kandela I, Zervantonakis I; Reproducibility Project: Cancer Biology; Reproducibility Project Cancer Biology.

Elife. 2015 May 5;4:e06847. doi: 10.7554/eLife.06847.

20.

Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection.

Swanson KI, Clark PA, Zhang RR, Kandela IK, Farhoud M, Weichert JP, Kuo JS.

Neurosurgery. 2015 Feb;76(2):115-23; discussion 123-4. doi: 10.1227/NEU.0000000000000622.

21.

Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.

Dalva-Aydemir S, Bajpai R, Martinez M, Adekola KU, Kandela I, Wei C, Singhal S, Koblinski JE, Raje NS, Rosen ST, Shanmugam M.

Clin Cancer Res. 2015 Mar 1;21(5):1161-71. doi: 10.1158/1078-0432.CCR-14-1088. Epub 2014 Dec 26.

22.

Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars.

Dam DH, Culver KS, Kandela I, Lee RC, Chandra K, Lee H, Mantis C, Ugolkov A, Mazar AP, Odom TW.

Nanomedicine. 2015 Apr;11(3):671-9. doi: 10.1016/j.nano.2014.10.005. Epub 2014 Nov 18.

23.

The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, Mazar A, Evens AM.

Clin Cancer Res. 2014 Dec 1;20(23):6023-33. doi: 10.1158/1078-0432.CCR-14-1532. Epub 2014 Oct 14.

24.

Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.

Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, Pazoles CJ, Pickhardt PJ, Kuo JS.

Sci Transl Med. 2014 Jun 11;6(240):240ra75. doi: 10.1126/scitranslmed.3007646.

25.

Robust structure and reactivity of aqueous arsenous acid-platinum(II) anticancer complexes.

Miodragović ĐU, Quentzel JA, Kurutz JW, Stern CL, Ahn RW, Kandela I, Mazar A, O'Halloran TV.

Angew Chem Int Ed Engl. 2013 Oct 4;52(41):10749-52. doi: 10.1002/anie.201303251. Epub 2013 Aug 22. No abstract available.

26.

Immuno-EM using colloidal metal nanoparticles and electron spectroscopic imaging for co-localization at high spatial resolution.

Bleher R, Kandela I, Meyer DA, Albrecht RM.

J Microsc. 2008 Jun;230(Pt 3):388-95. doi: 10.1111/j.1365-2818.2008.01997.x.

27.

Immunolabeling for correlative light and electron microscopy on ultrathin cryosections.

Kandela IK, Bleher R, Albrecht RM.

Microsc Microanal. 2008 Apr;14(2):159-65. doi: 10.1017/S1431927608080239. Epub 2008 Mar 3.

PMID:
18312726
28.

Multiple correlative immunolabeling for light and electron microscopy using fluorophores and colloidal metal particles.

Kandela IK, Bleher R, Albrecht RM.

J Histochem Cytochem. 2007 Oct;55(10):983-90. Epub 2007 Jul 24.

PMID:
17652267
30.
31.

Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells.

Kandela IK, Bartlett JA, Indig GL.

Photochem Photobiol Sci. 2002 May;1(5):309-14.

PMID:
12653467

Supplemental Content

Loading ...
Support Center